Andrew Bradford
Concepts (333)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 7 | 2021 | 144 | 2.020 |
Why?
| Follicle Stimulating Hormone | 13 | 2023 | 216 | 1.870 |
Why?
| Luteinizing Hormone | 13 | 2022 | 173 | 1.650 |
Why?
| Hyperlipidemias | 3 | 2022 | 128 | 1.120 |
Why?
| Hyperinsulinism | 3 | 2022 | 107 | 1.110 |
Why?
| Leiomyoma | 3 | 2019 | 45 | 1.110 |
Why?
| Uterine Neoplasms | 3 | 2019 | 76 | 1.080 |
Why?
| E2F1 Transcription Factor | 7 | 2023 | 56 | 1.050 |
Why?
| Protein Kinase C-alpha | 3 | 2009 | 43 | 0.990 |
Why?
| Prolactin | 9 | 2022 | 96 | 0.990 |
Why?
| Obesity | 13 | 2023 | 2746 | 0.970 |
Why?
| Pituitary Gland | 7 | 2021 | 163 | 0.910 |
Why?
| Human Growth Hormone | 1 | 2022 | 37 | 0.840 |
Why?
| Metabolic Syndrome | 3 | 2021 | 394 | 0.840 |
Why?
| Gene Expression Profiling | 6 | 2019 | 1597 | 0.810 |
Why?
| Proto-Oncogene Proteins | 9 | 2015 | 618 | 0.800 |
Why?
| Soybean Oil | 1 | 2021 | 12 | 0.800 |
Why?
| Corpus Luteum | 3 | 2016 | 21 | 0.800 |
Why?
| Phospholipids | 2 | 2021 | 208 | 0.730 |
Why?
| Protein Kinase C-delta | 4 | 2009 | 69 | 0.710 |
Why?
| Leiomyosarcoma | 1 | 2019 | 23 | 0.700 |
Why?
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 1167 | 0.700 |
Why?
| Promoter Regions, Genetic | 14 | 2023 | 1158 | 0.650 |
Why?
| Insulin | 5 | 2022 | 2162 | 0.630 |
Why?
| Cell Proliferation | 7 | 2015 | 2275 | 0.600 |
Why?
| Gene Expression Regulation | 11 | 2023 | 2445 | 0.560 |
Why?
| High Fructose Corn Syrup | 1 | 2015 | 10 | 0.540 |
Why?
| Granulosa Cells | 1 | 2015 | 30 | 0.530 |
Why?
| Signal Transduction | 11 | 2021 | 4709 | 0.530 |
Why?
| Apoptosis | 10 | 2023 | 2484 | 0.530 |
Why?
| Weight Gain | 2 | 2016 | 493 | 0.530 |
Why?
| Proto-Oncogene Proteins c-ets | 8 | 2007 | 51 | 0.510 |
Why?
| Fibroblast Growth Factor 2 | 3 | 2006 | 91 | 0.480 |
Why?
| Adenocarcinoma | 3 | 2009 | 812 | 0.460 |
Why?
| Dietary Fats | 1 | 2015 | 322 | 0.450 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1059 | 0.450 |
Why?
| Transcription Factors | 8 | 2018 | 1570 | 0.440 |
Why?
| DNA-Binding Proteins | 8 | 2018 | 1346 | 0.430 |
Why?
| Cross-Over Studies | 3 | 2022 | 456 | 0.410 |
Why?
| Gonadotropins | 3 | 2023 | 37 | 0.400 |
Why?
| MicroRNAs | 2 | 2015 | 637 | 0.400 |
Why?
| Aromatase Inhibitors | 3 | 2020 | 52 | 0.400 |
Why?
| E2F Transcription Factors | 4 | 2023 | 55 | 0.400 |
Why?
| Fibroblast Growth Factors | 3 | 2021 | 175 | 0.390 |
Why?
| Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.380 |
Why?
| Homeodomain Proteins | 5 | 2012 | 468 | 0.370 |
Why?
| Estradiol | 5 | 2023 | 476 | 0.360 |
Why?
| Cell Line, Tumor | 10 | 2021 | 2851 | 0.340 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 155 | 0.340 |
Why?
| Female | 31 | 2023 | 61564 | 0.330 |
Why?
| Hydrocortisone | 2 | 2022 | 273 | 0.320 |
Why?
| RNA, Messenger | 2 | 2015 | 2657 | 0.320 |
Why?
| Ovarian Neoplasms | 1 | 2012 | 420 | 0.300 |
Why?
| Menstrual Cycle | 2 | 2019 | 113 | 0.300 |
Why?
| Growth Hormone | 3 | 2022 | 108 | 0.280 |
Why?
| Genes, Tumor Suppressor | 4 | 2023 | 77 | 0.270 |
Why?
| MAP Kinase Signaling System | 2 | 2006 | 292 | 0.260 |
Why?
| Cell Cycle Proteins | 4 | 2023 | 565 | 0.260 |
Why?
| Humans | 36 | 2023 | 118972 | 0.230 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 109 | 0.230 |
Why?
| rac1 GTP-Binding Protein | 1 | 2003 | 58 | 0.230 |
Why?
| Transcription Factor DP1 | 2 | 2023 | 21 | 0.220 |
Why?
| Gonadotropin-Releasing Hormone | 4 | 2021 | 193 | 0.220 |
Why?
| Pituitary Hormones | 1 | 2022 | 16 | 0.220 |
Why?
| Transcription, Genetic | 3 | 2009 | 1323 | 0.210 |
Why?
| Thyroid Hormones | 1 | 2022 | 55 | 0.210 |
Why?
| Transcription Factor Pit-1 | 6 | 2003 | 23 | 0.210 |
Why?
| Thyrotropin | 1 | 2022 | 105 | 0.210 |
Why?
| Hypothalamus | 2 | 2014 | 155 | 0.210 |
Why?
| Tandem Mass Spectrometry | 2 | 2015 | 421 | 0.210 |
Why?
| Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 237 | 0.200 |
Why?
| Protein Kinase C | 1 | 2003 | 297 | 0.200 |
Why?
| Animals | 18 | 2016 | 33381 | 0.200 |
Why?
| Tumor Cells, Cultured | 4 | 2007 | 874 | 0.200 |
Why?
| Emulsions | 1 | 2021 | 45 | 0.200 |
Why?
| Heparin | 1 | 2022 | 230 | 0.190 |
Why?
| Phosphorylation | 4 | 2009 | 1633 | 0.190 |
Why?
| Leptin | 1 | 2022 | 231 | 0.190 |
Why?
| Thinness | 1 | 2021 | 91 | 0.190 |
Why?
| Lipids | 2 | 2022 | 607 | 0.190 |
Why?
| Adiponectin | 1 | 2022 | 226 | 0.190 |
Why?
| Fatty Acids, Nonesterified | 1 | 2021 | 167 | 0.190 |
Why?
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 11 | 0.180 |
Why?
| Creatinine | 1 | 2022 | 491 | 0.180 |
Why?
| Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 18 | 0.180 |
Why?
| Wnt Proteins | 1 | 2021 | 140 | 0.180 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 160 | 0.180 |
Why?
| Rats | 9 | 2006 | 5392 | 0.180 |
Why?
| Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.180 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 287 | 0.180 |
Why?
| Chitinase-3-Like Protein 1 | 1 | 2019 | 17 | 0.180 |
Why?
| Cell Cycle | 2 | 2015 | 550 | 0.180 |
Why?
| Wnt Signaling Pathway | 1 | 2021 | 150 | 0.180 |
Why?
| Intramolecular Oxidoreductases | 1 | 2019 | 59 | 0.170 |
Why?
| beta Catenin | 1 | 2021 | 219 | 0.170 |
Why?
| Eicosapentaenoic Acid | 1 | 2019 | 28 | 0.170 |
Why?
| Docosahexaenoic Acids | 1 | 2019 | 70 | 0.170 |
Why?
| Cytoskeletal Proteins | 1 | 2019 | 146 | 0.170 |
Why?
| Follicular Phase | 2 | 2015 | 41 | 0.170 |
Why?
| Gene Knockdown Techniques | 2 | 2009 | 311 | 0.160 |
Why?
| Estrogens | 3 | 2019 | 328 | 0.160 |
Why?
| Estrone | 2 | 2015 | 36 | 0.160 |
Why?
| Immunoenzyme Techniques | 2 | 2009 | 195 | 0.160 |
Why?
| Pituitary Gland, Anterior | 1 | 1997 | 46 | 0.160 |
Why?
| Microtubule-Associated Proteins | 1 | 2019 | 188 | 0.160 |
Why?
| Etoposide | 2 | 2009 | 149 | 0.160 |
Why?
| Fibroblasts | 3 | 2018 | 842 | 0.150 |
Why?
| Genes, p16 | 1 | 2016 | 18 | 0.150 |
Why?
| Aromatase | 2 | 2014 | 31 | 0.150 |
Why?
| Oncogene Proteins | 1 | 1996 | 52 | 0.140 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 371 | 0.140 |
Why?
| Genes, ras | 2 | 1997 | 95 | 0.140 |
Why?
| Dietary Supplements | 2 | 2019 | 467 | 0.140 |
Why?
| Enzyme Activation | 2 | 2009 | 828 | 0.130 |
Why?
| Ovulation | 1 | 2015 | 41 | 0.130 |
Why?
| Blotting, Western | 2 | 2009 | 1194 | 0.130 |
Why?
| Cumulus Cells | 1 | 2015 | 6 | 0.130 |
Why?
| Molecular Sequence Annotation | 1 | 2015 | 91 | 0.130 |
Why?
| Adult | 12 | 2021 | 31512 | 0.130 |
Why?
| Pregnancy | 3 | 2023 | 5690 | 0.130 |
Why?
| Diagnosis, Differential | 1 | 2019 | 1384 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 341 | 0.130 |
Why?
| Tumor Suppressor Protein p14ARF | 1 | 2014 | 6 | 0.130 |
Why?
| Sensitivity and Specificity | 1 | 2019 | 1795 | 0.120 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2015 | 190 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 125 | 0.120 |
Why?
| Cytokines | 3 | 2021 | 1900 | 0.120 |
Why?
| Blood Chemical Analysis | 1 | 2015 | 95 | 0.120 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2018 | 455 | 0.120 |
Why?
| Hormone Antagonists | 1 | 2014 | 41 | 0.120 |
Why?
| Circadian Rhythm | 1 | 2017 | 401 | 0.120 |
Why?
| Luteal Phase | 1 | 2014 | 44 | 0.120 |
Why?
| Transfection | 3 | 2009 | 888 | 0.120 |
Why?
| Repressor Proteins | 1 | 1997 | 377 | 0.120 |
Why?
| Diet, High-Fat | 1 | 2015 | 247 | 0.120 |
Why?
| Neoplasms, Experimental | 1 | 2014 | 158 | 0.120 |
Why?
| Postmenopause | 1 | 2015 | 305 | 0.110 |
Why?
| RNA Interference | 2 | 2018 | 460 | 0.110 |
Why?
| Breast Neoplasms | 3 | 2012 | 1965 | 0.110 |
Why?
| DNA Fingerprinting | 1 | 2012 | 26 | 0.110 |
Why?
| RNA, Small Interfering | 2 | 2018 | 564 | 0.110 |
Why?
| Base Sequence | 3 | 2012 | 2159 | 0.110 |
Why?
| DNA, Complementary | 2 | 2012 | 268 | 0.100 |
Why?
| Cell Line | 5 | 2018 | 2707 | 0.100 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 289 | 0.100 |
Why?
| Weight Loss | 1 | 2016 | 655 | 0.100 |
Why?
| Testosterone | 1 | 2015 | 351 | 0.100 |
Why?
| Pulsatile Flow | 1 | 2011 | 54 | 0.100 |
Why?
| Neoplasms | 2 | 2023 | 2179 | 0.100 |
Why?
| Cell Survival | 2 | 2021 | 1047 | 0.100 |
Why?
| Mutation | 1 | 2021 | 3457 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 982 | 0.090 |
Why?
| Colony-Forming Units Assay | 1 | 2009 | 93 | 0.090 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 65 | 0.090 |
Why?
| Adiposity | 1 | 2015 | 516 | 0.090 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 69 | 0.090 |
Why?
| Luciferases | 1 | 2009 | 143 | 0.090 |
Why?
| Transforming Growth Factor beta | 1 | 2012 | 462 | 0.090 |
Why?
| Progesterone | 3 | 2016 | 242 | 0.090 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2009 | 83 | 0.090 |
Why?
| Cyclin D1 | 1 | 2009 | 61 | 0.090 |
Why?
| Models, Biological | 2 | 2016 | 1715 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 770 | 0.090 |
Why?
| NIH 3T3 Cells | 1 | 2009 | 139 | 0.090 |
Why?
| Membrane Proteins | 1 | 2015 | 1055 | 0.090 |
Why?
| Mutant Proteins | 1 | 2009 | 100 | 0.090 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 453 | 0.080 |
Why?
| Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.080 |
Why?
| PTEN Phosphohydrolase | 1 | 2009 | 143 | 0.080 |
Why?
| Neoplastic Stem Cells | 1 | 2012 | 336 | 0.080 |
Why?
| Young Adult | 7 | 2020 | 10793 | 0.080 |
Why?
| RNA, Neoplasm | 1 | 2008 | 77 | 0.080 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 285 | 0.080 |
Why?
| Myometrium | 1 | 2008 | 35 | 0.080 |
Why?
| DNA, Neoplasm | 1 | 2008 | 154 | 0.080 |
Why?
| Mice, Nude | 1 | 2009 | 663 | 0.080 |
Why?
| Rabbits | 1 | 2009 | 780 | 0.080 |
Why?
| Isoenzymes | 2 | 2003 | 297 | 0.080 |
Why?
| Neoplasm Invasiveness | 1 | 2009 | 462 | 0.080 |
Why?
| Cell Adhesion | 1 | 2009 | 443 | 0.080 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 420 | 0.080 |
Why?
| Active Transport, Cell Nucleus | 1 | 2007 | 113 | 0.080 |
Why?
| DNA Primers | 1 | 2008 | 533 | 0.070 |
Why?
| Subcellular Fractions | 1 | 2006 | 84 | 0.070 |
Why?
| HeLa Cells | 2 | 2000 | 583 | 0.070 |
Why?
| Proto-Oncogene Proteins c-raf | 2 | 1997 | 46 | 0.070 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 58 | 0.070 |
Why?
| Mammary Glands, Human | 1 | 2007 | 61 | 0.070 |
Why?
| DNA Damage | 1 | 2009 | 357 | 0.070 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2006 | 87 | 0.070 |
Why?
| Immunoprecipitation | 1 | 2006 | 161 | 0.070 |
Why?
| Growth Hormone-Releasing Hormone | 1 | 2006 | 27 | 0.070 |
Why?
| raf Kinases | 1 | 2006 | 12 | 0.070 |
Why?
| Ultraviolet Rays | 1 | 2009 | 381 | 0.070 |
Why?
| Autocrine Communication | 1 | 2006 | 42 | 0.070 |
Why?
| Receptors, Growth Factor | 1 | 2006 | 50 | 0.070 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 175 | 0.070 |
Why?
| Protein Kinase Inhibitors | 2 | 2009 | 811 | 0.070 |
Why?
| Adolescent | 7 | 2021 | 18480 | 0.070 |
Why?
| Prostate | 1 | 2007 | 158 | 0.070 |
Why?
| Paracrine Communication | 1 | 2006 | 57 | 0.070 |
Why?
| Prospective Studies | 4 | 2023 | 6471 | 0.070 |
Why?
| Mice | 4 | 2012 | 15520 | 0.070 |
Why?
| Caspases | 1 | 2006 | 269 | 0.070 |
Why?
| Reproduction | 1 | 2007 | 189 | 0.070 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 180 | 0.070 |
Why?
| ras Proteins | 1 | 2006 | 141 | 0.070 |
Why?
| Body Mass Index | 3 | 2021 | 2092 | 0.060 |
Why?
| Hypothalamo-Hypophyseal System | 2 | 2017 | 195 | 0.060 |
Why?
| Biomarkers | 1 | 2015 | 3588 | 0.060 |
Why?
| Cell Movement | 1 | 2009 | 896 | 0.060 |
Why?
| Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| Ovulation Induction | 2 | 2015 | 50 | 0.060 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 298 | 0.060 |
Why?
| Hypogonadism | 2 | 2015 | 77 | 0.060 |
Why?
| Cell Nucleus | 1 | 2007 | 580 | 0.060 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 46 | 0.060 |
Why?
| Middle Aged | 2 | 2019 | 27617 | 0.060 |
Why?
| Inflammation | 1 | 2015 | 2566 | 0.060 |
Why?
| Phospholipid Ethers | 1 | 2003 | 7 | 0.060 |
Why?
| Thiocarbamates | 1 | 2003 | 8 | 0.060 |
Why?
| Bridged-Ring Compounds | 1 | 2003 | 11 | 0.060 |
Why?
| Culture Media, Serum-Free | 1 | 2003 | 42 | 0.060 |
Why?
| Thyroid Neoplasms | 1 | 2007 | 278 | 0.060 |
Why?
| Thiones | 1 | 2003 | 14 | 0.060 |
Why?
| Norbornanes | 1 | 2003 | 13 | 0.060 |
Why?
| E2F3 Transcription Factor | 1 | 2023 | 8 | 0.060 |
Why?
| Chromones | 1 | 2003 | 37 | 0.060 |
Why?
| Follicle Stimulating Hormone, Human | 1 | 2023 | 11 | 0.060 |
Why?
| Gene Expression | 2 | 2021 | 1489 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2007 | 1691 | 0.060 |
Why?
| Androstadienes | 1 | 2003 | 94 | 0.060 |
Why?
| Morpholines | 1 | 2003 | 106 | 0.050 |
Why?
| Molecular Sequence Data | 4 | 2012 | 2871 | 0.050 |
Why?
| Cluster Analysis | 2 | 2015 | 481 | 0.050 |
Why?
| Protein Isoforms | 1 | 2003 | 345 | 0.050 |
Why?
| Models, Molecular | 1 | 2007 | 1435 | 0.050 |
Why?
| Pituitary Neoplasms | 1 | 2003 | 165 | 0.050 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 28 | 0.050 |
Why?
| Transcription Factor CHOP | 1 | 2021 | 29 | 0.050 |
Why?
| Fat Emulsions, Intravenous | 1 | 2021 | 31 | 0.050 |
Why?
| Indazoles | 1 | 2021 | 60 | 0.050 |
Why?
| Aged | 1 | 2019 | 19657 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 2 | 2004 | 363 | 0.050 |
Why?
| Genetic Fitness | 1 | 2021 | 55 | 0.050 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2021 | 97 | 0.050 |
Why?
| Heat-Shock Proteins | 1 | 2021 | 129 | 0.050 |
Why?
| Glucose Clamp Technique | 1 | 2021 | 194 | 0.050 |
Why?
| Imidazoles | 1 | 2021 | 232 | 0.050 |
Why?
| Pancreatic Neoplasms | 1 | 2007 | 734 | 0.050 |
Why?
| Disease Susceptibility | 1 | 2021 | 331 | 0.040 |
Why?
| DNA | 2 | 1997 | 1388 | 0.040 |
Why?
| ADP-Ribosylation Factors | 1 | 2018 | 17 | 0.040 |
Why?
| Progestins | 1 | 2019 | 77 | 0.040 |
Why?
| Cell Differentiation | 1 | 2006 | 1753 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2021 | 356 | 0.040 |
Why?
| Recurrence | 1 | 2021 | 975 | 0.040 |
Why?
| Academic Medical Centers | 1 | 2021 | 422 | 0.040 |
Why?
| Dimerization | 1 | 2018 | 183 | 0.040 |
Why?
| Pyridines | 1 | 2021 | 440 | 0.040 |
Why?
| Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| Ectopic Gene Expression | 1 | 2016 | 3 | 0.040 |
Why?
| Disease Management | 1 | 2021 | 571 | 0.040 |
Why?
| ets-Domain Protein Elk-1 | 1 | 1996 | 14 | 0.040 |
Why?
| Catalysis | 1 | 1997 | 295 | 0.040 |
Why?
| Retinoblastoma Protein | 1 | 2016 | 52 | 0.040 |
Why?
| Transduction, Genetic | 1 | 1996 | 116 | 0.040 |
Why?
| Pituitary-Adrenal System | 1 | 2017 | 159 | 0.040 |
Why?
| Hormones | 1 | 2016 | 135 | 0.030 |
Why?
| Infertility, Female | 1 | 2016 | 94 | 0.030 |
Why?
| Administration, Cutaneous | 1 | 2015 | 119 | 0.030 |
Why?
| Oocyte Retrieval | 1 | 2015 | 12 | 0.030 |
Why?
| Limit of Detection | 1 | 2015 | 55 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 2015 | 229 | 0.030 |
Why?
| Neovascularization, Physiologic | 1 | 2016 | 181 | 0.030 |
Why?
| Genes, Transgenic, Suicide | 1 | 2014 | 8 | 0.030 |
Why?
| Binding Sites | 1 | 1997 | 1224 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2015 | 79 | 0.030 |
Why?
| Trans-Activators | 1 | 1997 | 373 | 0.030 |
Why?
| Protein-Tyrosine Kinases | 1 | 1997 | 407 | 0.030 |
Why?
| Ovary | 1 | 2015 | 205 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 1997 | 653 | 0.030 |
Why?
| Chromosome Mapping | 1 | 1995 | 510 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.030 |
Why?
| Anions | 1 | 2013 | 31 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2015 | 379 | 0.030 |
Why?
| Molecular Conformation | 1 | 2013 | 146 | 0.030 |
Why?
| Chromatography, Liquid | 1 | 2015 | 355 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 407 | 0.030 |
Why?
| Genetic Therapy | 1 | 2014 | 267 | 0.030 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2012 | 155 | 0.030 |
Why?
| Heterografts | 1 | 2012 | 130 | 0.030 |
Why?
| Gene Library | 1 | 2012 | 127 | 0.030 |
Why?
| Protein Binding | 1 | 1997 | 1975 | 0.020 |
Why?
| Male | 4 | 2017 | 57801 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2015 | 1171 | 0.020 |
Why?
| Nitriles | 1 | 2011 | 155 | 0.020 |
Why?
| Protein Kinases | 1 | 1992 | 310 | 0.020 |
Why?
| Triazoles | 1 | 2011 | 134 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 814 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2012 | 755 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2011 | 736 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2017 | 4552 | 0.020 |
Why?
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 7 | 0.020 |
Why?
| Receptors, Neuropeptide | 1 | 2006 | 11 | 0.020 |
Why?
| Transcriptome | 1 | 2012 | 756 | 0.020 |
Why?
| Prognosis | 1 | 2012 | 3443 | 0.020 |
Why?
| Liver | 1 | 1992 | 1816 | 0.010 |
Why?
| Suppression, Genetic | 1 | 2003 | 25 | 0.010 |
Why?
| Genetic Vectors | 1 | 2004 | 302 | 0.010 |
Why?
| Genes, Dominant | 1 | 2003 | 96 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2012 | 3730 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2003 | 348 | 0.010 |
Why?
| Amino Acid Sequence | 2 | 1997 | 2071 | 0.010 |
Why?
| Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| Sequence Alignment | 1 | 1997 | 336 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 1997 | 372 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 1997 | 522 | 0.010 |
Why?
| Drosophila Proteins | 1 | 1997 | 171 | 0.010 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 551 | 0.010 |
Why?
| Biological Evolution | 1 | 1997 | 443 | 0.010 |
Why?
| Chromatography, Ion Exchange | 1 | 1992 | 51 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1992 | 133 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1992 | 394 | 0.010 |
Why?
| Molecular Weight | 1 | 1992 | 343 | 0.010 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 332 | 0.010 |
Why?
| Cytosol | 1 | 1992 | 221 | 0.010 |
Why?
| Substrate Specificity | 1 | 1992 | 371 | 0.010 |
Why?
| Peptides | 1 | 1997 | 879 | 0.010 |
Why?
| Oligopeptides | 1 | 1992 | 252 | 0.010 |
Why?
| Cells, Cultured | 1 | 1997 | 4077 | 0.010 |
Why?
| Kinetics | 1 | 1992 | 1624 | 0.010 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|